Get notified when TLS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Ceo (new) — CEO taking medical leave with no specified return date creates leadership uncertainty despite interim arrangement.
Telos CEO takes medical leave; Q1 results to exceed guidance amid leadership transition
Filed April 29, 2026 · Period ending April 28, 2026 · ~1 min read
Key Changes
-
high
CEO John B. Wood taking medical leave of uncertain duration; three executives (Griffin, Bendza, Robbins) sharing interim CEO duties under board oversight, creating unusual leadership structure.
Item 5.02 verify on EDGAR → -
high
Company expects Q1 revenue and Adjusted EBITDA above high end of guidance range provided March 16; full-year outlook to be reaffirmed on May 11 earnings call.
Item 7.01 view on EDGAR → -
medium
Fred Schaufeld appointed interim Chairman of the Board, replacing Wood in board leadership role during medical leave period.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade TLS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify